SLNO vs. NVDA
Compare and contrast key facts about Soleno Therapeutics, Inc. (SLNO) and NVIDIA Corporation (NVDA).
Performance
SLNO vs. NVDA - Performance Comparison
Loading graphics...
SLNO vs. NVDA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SLNO Soleno Therapeutics, Inc. | -27.69% | 3.00% | 11.68% | 1,932.83% | -67.80% | -78.76% | -34.35% | 71.93% | -5.00% | -55.56% |
NVDA NVIDIA Corporation | -6.48% | 38.92% | 171.25% | 239.02% | -50.26% | 125.48% | 122.30% | 76.94% | -30.82% | 81.99% |
Fundamentals
SLNO:
$1.82B
NVDA:
$4.26T
SLNO:
$0.39
NVDA:
$4.90
SLNO:
85.34
NVDA:
35.61
SLNO:
9.36
NVDA:
19.80
SLNO:
4.04
NVDA:
27.09
SLNO:
$190.41M
NVDA:
$215.94B
SLNO:
$96.84M
NVDA:
$153.46B
SLNO:
$9.41M
NVDA:
$144.55B
Returns By Period
In the year-to-date period, SLNO achieves a -27.69% return, which is significantly lower than NVDA's -6.48% return. Over the past 10 years, SLNO has underperformed NVDA with an annualized return of -9.78%, while NVDA has yielded a comparatively higher 69.61% annualized return.
SLNO
- 1D
- 9.99%
- 1M
- -14.31%
- YTD
- -27.69%
- 6M
- -50.47%
- 1Y
- -53.14%
- 3Y*
- 150.11%
- 5Y*
- 11.25%
- 10Y*
- -9.78%
NVDA
- 1D
- 5.59%
- 1M
- -1.57%
- YTD
- -6.48%
- 6M
- -6.52%
- 1Y
- 60.95%
- 3Y*
- 84.54%
- 5Y*
- 66.14%
- 10Y*
- 69.61%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SLNO vs. NVDA — Risk / Return Rank
SLNO
NVDA
SLNO vs. NVDA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Soleno Therapeutics, Inc. (SLNO) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SLNO | NVDA | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.83 | 1.48 | -2.31 |
Sortino ratioReturn per unit of downside risk | -1.09 | 2.17 | -3.26 |
Omega ratioGain probability vs. loss probability | 0.86 | 1.27 | -0.42 |
Calmar ratioReturn relative to maximum drawdown | -0.81 | 2.92 | -3.73 |
Martin ratioReturn relative to average drawdown | -1.51 | 7.39 | -8.90 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| SLNO | NVDA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.83 | 1.48 | -2.31 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.05 | 1.29 | -1.24 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.05 | 1.40 | -1.45 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.09 | 0.61 | -0.71 |
Correlation
The correlation between SLNO and NVDA is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
SLNO vs. NVDA - Dividend Comparison
SLNO has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SLNO Soleno Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVDA NVIDIA Corporation | 0.02% | 0.02% | 0.03% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% |
Drawdowns
SLNO vs. NVDA - Drawdown Comparison
The maximum SLNO drawdown since its inception was -99.86%, which is greater than NVDA's maximum drawdown of -89.72%. Use the drawdown chart below to compare losses from any high point for SLNO and NVDA.
Loading graphics...
Drawdown Indicators
| SLNO | NVDA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.86% | -89.72% | -10.14% |
Max Drawdown (1Y)Largest decline over 1 year | -66.04% | -20.21% | -45.83% |
Max Drawdown (5Y)Largest decline over 5 years | -95.49% | -66.34% | -29.15% |
Max Drawdown (10Y)Largest decline over 10 years | -99.13% | -66.34% | -32.79% |
Current DrawdownCurrent decline from peak | -94.90% | -15.76% | -79.14% |
Average DrawdownAverage peak-to-trough decline | -90.57% | -36.40% | -54.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.50% | 7.99% | +27.51% |
Volatility
SLNO vs. NVDA - Volatility Comparison
Soleno Therapeutics, Inc. (SLNO) has a higher volatility of 17.95% compared to NVIDIA Corporation (NVDA) at 10.46%. This indicates that SLNO's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| SLNO | NVDA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.95% | 10.46% | +7.49% |
Volatility (6M)Calculated over the trailing 6-month period | 50.62% | 25.91% | +24.71% |
Volatility (1Y)Calculated over the trailing 1-year period | 64.08% | 41.44% | +22.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 243.38% | 51.74% | +191.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 185.10% | 49.85% | +135.25% |
Financials
SLNO vs. NVDA - Financials Comparison
This section allows you to compare key financial metrics between Soleno Therapeutics, Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities